Samarth Kulkarni
@CrisprSam
Followers
5K
Following
104
Media
11
Statuses
250
CEO and Chairman at CRISPR Therapeutics @CRISPRTX, which is pioneering a new era of gene-based medicines. Tweets are my own.
Boston, MA
Joined October 2015
Thank you! It’s a reflection of all the employees who are dedicated to the cause of bringing cures to patients!.
Congrats to @CrisprSam - the CEO of @CRISPRTX on being part of the TIME100’s Health list - honoring the 100 most influential people in health today. $CRSP is the first-ever company to receive an FDA approval for its Gene Editing treatment - CASGEVY. A well-deserved recognition!
7
0
31
Congrats @CRISPRTX on being named to the @TIME Most Influential Companies of 2025 list! Proud of the full company and excited for the future of genetic medicine. #CRISPRTX #TIME100Companies.
Introducing TIME's most influential companies of 2025: 100 companies around the world that shaped culture, made new strides, reached milestones, and more
3
1
32
We are excited to announce our collaboration with Sirius Tx. This strategic partnership expands our therapeutic toolkit & broadens our cardiovascular portfolio. We look forward to working closely with the Sirius team to advance this exciting asset.
Today, we announced a collaboration with Sirius Tx to co-develop SRSD107, a next generation, long-acting Factor XI siRNA for the treatment of thromboembolic disorders. This will expand our cardiovascular portfolio and broaden our therapeutic toolkit.
7
2
39
Thank you @TIME for naming me on the #TIME100HEALTH list! Honored to be included and congrats to all the 2025 honorees.
TIME's new cover: Meet this year's #TIME100Health, a community of leaders—scientists, doctors, advocates, educators, and policy-makers, among others—who are changing the health of the world.
5
1
14
Proud to share our latest business updates and positive top-line results from our Phase 1 clinical trial of CTX310 targeting ANGPTL3. Congratulations to our team and all who contributed to this milestone! @CRISPRTX.
7
4
62
RT @JMaraganore: U.S. leadership in biotech is a national security, economic, and public health imperative. With the attack on science and….
0
13
0
RT @JMaraganore: This is a major setback for FDA, improvements in regulatory science, and advancement of innovation for patients! https://t….
0
1
0
RT @HassanAesthetic: @olagherej interview and how CRISPR can cure patients. We also discuss the other challenges in this space. https://t.c….
0
1
0
Agree.
India’s Underestimated Gene Revolution: Why CRISPR, Not AI, Should Be the Nation’s Next Big Leap
9
0
19
RT @CRISPRTX: We are pleased to invite Briggs Morrison, M.D., to join our Board of Directors. His extensive experience in the pharmaceutica….
0
8
0
RT @UrnovFyodor: Dr Peter Marks (head of FDA CBER) makes an apt analogy between #CRISPR and razors in this @NPR @robsteinnews piece about….
0
7
0
This is a wonderful recognition for CRISPR! Congrats to all the innovators for all these groundbreaking inventions.
We’re proud to share that we’ve been named on the @TIME Best Inventions of 2024 list! This list recognizes a wide variety of new products, software or services that are making a difference in the world. #TIMEBestInventions
4
4
45
RT @VamsiMootha: Clearly, we’re now in the golden age of biology: physiology/medicine Nobel to tiny RNAs; physics Nobel to neural network….
0
86
0
Incredible to see Jimi summit Kilimanjaro! #SickleCellAwarenessMonth #CRISPR.
Watch Jimi Olaghere, the first sickle cell disease patient to summit Kilimanjaro.
5
1
36
Thank you@FierceBiotech, @FiercePharma & @FierceHealth for this recognition and congrats to the full @CRISPRTX team! #CRISPRTX #Fierce50.
We're proud that Fierce named @CRISPRTX as a 2024 Fierce 50 honoree in the Breakthroughs category! #Fierce50 highlights companies driving advancements in medicine, fostering innovation & shaping the future of healthcare. Learn more:
1
0
13
Collab with NHS England and NICE to reach this landmark agreement that recognizes the value that Casgevy can provide to patients, their families and the health care system.
5
6
66
Glad ARM @alliancerm is championing this cause!.
Some cell & gene therapies, including FDA-approved therapies to durably treat - & potentially cure - sickle cell disease, require chemotherapy which can cause infertility. No patient should have to choose between a transformative medicine & having biological children. 1/3
1
0
6
Glad there is increasing awareness of Lp(a) as a risk factor and increased testing!.
📢🔥Testing practices & clinical management Lp(a): 5-year analysis Hopkins-Lp(a) Study:.▪️Lp(a) elevated in 43% of pts w/ or at-risk of ASCVD who were tested .▪️Lipid Clinic ⬆️Lp(a) testing.▪️.@SethShayMartin @rblument1 . @hopkinsheart @CiccaroneCenter
0
0
7
Very important call to action by ARM! In many cases, a patients natural history data is a better comparator than a control arm in the trial.
Announcing a joint Call to Action 📣.➡️ By centralizing assessments currently performed separately by each Member State, the Joint Clinical Assessment (JCA) was created to reduce the time and cost of bringing new therapies to patients. 🧵1/4
0
0
3
Great to see you @berthacoombs and thanks for always putting patients first! #aspenideashealth.
$CRSP CEO Sam Kulkarni on making Crispr treatments like Casgevy more accessible says technology will help address this problem. #AspenIdeasHealth
0
0
10